Steven Lichtman
Stock Analyst at William Blair
(4.76)
# 607
Out of 4,534 analysts
991
Total ratings
53.4%
Success rate
13.8%
Average return
Main Sectors:
Stocks Rated by Steven Lichtman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GKOS Glaukos | Maintained: Buy | n/a | $155.46 | - | 15 | Jul 6, 2026 | |
| MMED MiniMed Group | Maintained: Buy | n/a | $16.92 | - | 2 | Jun 17, 2026 | |
| COO The Cooper Companies | Maintained: Buy | n/a | $71.59 | - | 30 | Jun 5, 2026 | |
| PODD Insulet | Maintained: Buy | n/a | $167.37 | - | 64 | Jun 4, 2026 | |
| DXCM DexCom | Maintained: Buy | n/a | $75.69 | - | 89 | May 15, 2026 | |
| ENOV Enovis | Maintained: Buy | n/a | $26.84 | - | 2 | May 8, 2026 | |
| RXST RxSight | Maintained: Hold | n/a | $5.61 | - | 15 | May 8, 2026 | |
| SGHT Sight Sciences | Reiterated: Buy | n/a | $5.04 | - | 3 | May 7, 2026 | |
| SWX: ALC Alcon Inc. | Maintained: Hold | n/a | $56.76 | - | 7 | May 6, 2026 | |
| SYK Stryker | Reiterated: Buy | n/a | $319.14 | - | 52 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $89.72 | - | 72 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $15 | $3.98 | +276.88% | 22 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $118 | $43.77 | +169.59% | 81 | Aug 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $7.5 | $16.50 | n/a | 22 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $73 → $78 | $76.01 | n/a | 69 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $87 → $116 | $75.17 | n/a | 14 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $16 | $13.71 | n/a | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $275 | $318.01 | n/a | 1 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $23.97 | n/a | 5 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $92 → $94 | $83.29 | n/a | 146 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 | $18.10 | n/a | 43 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $18.89 | n/a | 123 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 | $2.64 | n/a | 3 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 17 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.63 | n/a | 15 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.81 | n/a | 8 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.55 | n/a | 13 | Dec 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $237 | $283.94 | n/a | 1 | Feb 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.7169 | n/a | 11 | May 27, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.00 | n/a | 26 | Mar 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.7039 | n/a | 13 | Mar 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.50 | n/a | 1 | Oct 7, 2011 |
Glaukos
Jul 6, 2026
Maintained: Buy
Price Target: n/a
Current: $155.46
Upside: -
MiniMed Group
Jun 17, 2026
Maintained: Buy
Price Target: n/a
Current: $16.92
Upside: -
The Cooper Companies
Jun 5, 2026
Maintained: Buy
Price Target: n/a
Current: $71.59
Upside: -
Insulet
Jun 4, 2026
Maintained: Buy
Price Target: n/a
Current: $167.37
Upside: -
DexCom
May 15, 2026
Maintained: Buy
Price Target: n/a
Current: $75.69
Upside: -
Enovis
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $26.84
Upside: -
RxSight
May 8, 2026
Maintained: Hold
Price Target: n/a
Current: $5.61
Upside: -
Sight Sciences
May 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.04
Upside: -
Alcon Inc.
May 6, 2026
Maintained: Hold
Price Target: n/a
Current: $56.76
Upside: -
Stryker
May 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $319.14
Upside: -
Apr 29, 2026
Maintained: Hold
Price Target: n/a
Current: $89.72
Upside: -
Sep 5, 2025
Maintained: Buy
Price Target: $12 → $15
Current: $3.98
Upside: +276.88%
Aug 3, 2025
Maintained: Hold
Price Target: $118
Current: $43.77
Upside: +169.59%
May 14, 2025
Maintained: Buy
Price Target: $11 → $7.5
Current: $16.50
Upside: n/a
May 9, 2025
Maintained: Hold
Price Target: $73 → $78
Current: $76.01
Upside: n/a
Feb 26, 2025
Maintained: Buy
Price Target: $87 → $116
Current: $75.17
Upside: n/a
Jan 10, 2025
Maintained: Buy
Price Target: $13 → $16
Current: $13.71
Upside: n/a
Dec 16, 2024
Initiated Coverage: Buy
Price Target: $275
Current: $318.01
Upside: n/a
Nov 1, 2024
Maintained: Hold
Price Target: n/a
Current: $23.97
Upside: n/a
Aug 21, 2024
Maintained: Hold
Price Target: $92 → $94
Current: $83.29
Upside: n/a
Aug 2, 2024
Maintained: Buy
Price Target: $58
Current: $18.10
Upside: n/a
May 7, 2024
Downgraded: Hold
Price Target: n/a
Current: $18.89
Upside: n/a
Sep 19, 2023
Maintained: Buy
Price Target: $3.5
Current: $2.64
Upside: n/a
Feb 6, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 10, 2022
Downgraded: Hold
Price Target: n/a
Current: $2.63
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $1.81
Upside: n/a
Dec 18, 2018
Rated: Hold
Price Target: n/a
Current: $7.55
Upside: n/a
Feb 8, 2018
Reiterated: Buy
Price Target: $237
Current: $283.94
Upside: n/a
May 27, 2016
Reiterated: Hold
Price Target: n/a
Current: $0.7169
Upside: n/a
Mar 4, 2016
Downgraded: Hold
Price Target: n/a
Current: $3.00
Upside: n/a
Mar 13, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.7039
Upside: n/a
Oct 7, 2011
Downgraded: Hold
Price Target: n/a
Current: $1.50
Upside: n/a